Intelligence · Clinical pipeline
Metabolic & obesity R&D Pipeline
GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Quick answer
Metabolic & obesity: NovaPharmaNews indexes 39 metabolic & obesity clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. GLP-1, metabolic disease, obesity, and diabetes pipeline programs with sponsor and trial ID cross-links.
Top sponsors
- Takeda 75 programs
- NovoThirteen 61 programs
- First People's Hospital 38 programs
- Regeneron UK 35 programs
- Eli Lilly and 29 programs
- Chinese Academy of 26 programs
- United Therapeutics Europe 24 programs
- Boehringer Ingelheim 19 programs
- Anaxis Pharma 18 programs
- LEXICON PHARMACEUTICALS 16 programs
- George Institute for 15 programs
- Novo Nordisk A/S 14 programs
Pipeline programs
-
Botulinum toxin type A
Hospital Authority, Hong Kong
Obesity
1 trial -
Eloralintide
Eli Lilly and Company
Obesity
1 trial -
I8F-MC-GPIX
Eli Lilly Co.
Obesity
1 trial -
J1I-MC-GZBP
Eli Lilly Co.
Obesity
1 trial -
K9531-3107
Kailera Therapeutics
Obesity
1 trial -
KAI-9531
Kailera Therapeutics
Obesity
3 trials -
NN8022-4392
NovoThirteen
Obesity
1 trial -
NN9838-7749
NovoThirteen
Obesity
1 trial -
NN9838-7859
NovoThirteen
Obesity
1 trial -
Setmelanotide
Rhythm Pharmaceuticals Netherlands B.V.
Obesity
1 trial -
lorcaserin
BRIGHT MINDS BIOSCIENCES INC.
Obesity
1 trial -
ARO-INHBE
Arrowhead Pharmaceuticals Ireland Limited
Obesity
1 trial -
BC45538
Hoffmann-La Roche
Obesity
1 trial -
EP-005
Lacuna Pharma Pty Ltd
Obesity
1 trial -
ISIS-FGFR4RX
IONIS PHARMACEUTICALS INC
Obesity
1 trial -
KAI-7535
Kailera Therapeutics
Obesity
2 trials -
Naltrexone hydrochloride
BRIGHT MINDS BIOSCIENCES INC.
Obesity
1 trial -
Pramlintide+Metreleptin
Takeda
Obesity
1 trial -
TTP435
vTv Therapeutics
Obesity
1 trial -
Tirzepatide
Regeneron UK Limited
Obesity
1 trial -
Tradipitant
Vanda Pharmaceuticals Netherlands B.V.
Obesity
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial -
MBX 4291
MBX Biosciences
Obesity
1 trial -
Placebo
Rhythm Pharmaceuticals Netherlands B.V.
Obesity
1 trial -
RT-114 is the RaniPill capsule with PG-102 for the treatment of obesity
Rani Therapeutics Holdings
Obesity
1 trial -
ANGELO
The George Institute
Obesity
1 trial -
Berberine plus lifestyle intervention
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Candesartan and Hydrochlorothiazide
Takeda
Obesity
1 trial -
ESOMEPRAZOLE, ESOMEPRAZOLE
Fondazione Telethon ETS
obesity
1 trial -
EXPAREL
Pacira Ireland Limited
Obesity
1 trial -
Intravenous Ibuprofen
CUMBERLAND PHARMACEUTICALS INC
Obesity
1 trial -
NN9536-7752
NovoThirteen
Obesity
1 trial -
Pioglitazone
Takeda
Obesity
1 trial -
Semaglutide
United Therapeutics Europe Ltd
Obesity
1 trial -
Semaglutide B 3.0 mg/ml PDS290
Disc Medicine
obesity
1 trial -
Simvastatin
Hospital Authority, Hong Kong
Obesity
1 trial -
Iron Isomaltoside injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Oral supplementation of vitamin D
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Obesity
1 trial -
Phentermine
Takeda
Obesity
1 trial
Frequently asked questions
How many metabolic & obesity pipeline programs are tracked?
39 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.